ProfileGDS4814 / ILMN_1727462
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 56% 67% 66% 60% 63% 61% 68% 57% 71% 68% 58% 68% 58% 68% 47% 63% 67% 65% 64% 68% 69% 69% 71% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)52.729656
GSM780708Untreated after 4 days (C2_1)65.394467
GSM780709Untreated after 4 days (C3_1)61.822566
GSM780719Untreated after 4 days (C1_2)55.658660
GSM780720Untreated after 4 days (C2_2)58.618263
GSM780721Untreated after 4 days (C3_2)56.11861
GSM780710Trastuzumab treated after 4 days (T1_1)68.128268
GSM780711Trastuzumab treated after 4 days (T2_1)53.433357
GSM780712Trastuzumab treated after 4 days (T3_1)76.545671
GSM780722Trastuzumab treated after 4 days (T1_2)66.532368
GSM780723Trastuzumab treated after 4 days (T2_2)53.762858
GSM780724Trastuzumab treated after 4 days (T3_2)67.013468
GSM780713Pertuzumab treated after 4 days (P1_1)53.951358
GSM780714Pertuzumab treated after 4 days (P2_1)67.477568
GSM780715Pertuzumab treated after 4 days (P3_1)49.628847
GSM780725Pertuzumab treated after 4 days (P1_2)58.001563
GSM780726Pertuzumab treated after 4 days (P2_2)64.199667
GSM780727Pertuzumab treated after 4 days (P3_2)60.730365
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)58.857264
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)66.702268
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)69.833169
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)69.994769
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)76.311471